Rh typing is a standard part of a woman’s first prenatal visit. Sometimes, though, the results are anything but. Anywhere from 2 to 4 percent of women type as both Rh positive (D+) and Rh negative (D-). This inconsistency then influences how OB-GYNs interpret the data and develop a treatment plan.
Fill out the form below to download the Transfusion Commentary, "It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype," in which Dr. Connie Westhoff contributes, and read why Rh blood group discrepancies occur, what effect they have on obstetrics and how RHD genotyping may provide an effective solution.